Rockville-based AdLyfe is the latest company to receive a piece of the $84 million InvestMaryland fund.
Founded in 2003, the biotech company’s “Pronucleon technology platform is intended to help diagnose Alzheimer’s, Parkinson’s and other diseases early,” reports the Baltimore Business Journal.
Read the full story at the Baltimore Business Journal.
As Technically Baltimore has reported, the state’s $84 million venture capital fund will be paid out in $28 million installments over three years, with venture capital firms managing and investing two-thirds of the InvestMaryland fund money.
Before you go...
Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
